Growth Hormone Secretagogues

GHRP-2

Pralmorelin · Growth hormone releasing peptide 2

A potent ghrelin receptor agonist that stimulates strong, dose-dependent GH release.

Overview & Mechanism

Binds the GHS (ghrelin) receptor, triggering robust GH release from the pituitary; more potent than GHRP-6 with less hunger effect.

Research Dosage

Dose

100–300 mcg per dose

Route

Subcutaneous injection

Frequency

2–3 times daily

Cycle

4–8 weeks

Reconstitution & Storage

Reconstitution

Reconstitute a 5 mg vial with 2 mL of bacteriostatic water (2.5 mg/mL).

Storage

Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.

Safety & Side Effects

May increase appetite and cause mild cortisol/prolactin elevation. Avoid food around dosing.

Studies

GHRP-2 GH release in healthy men

GHRP-2 produced a dose-dependent GH release significantly greater than placebo in healthy male volunteers.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.